Loading...
Amarin Corporation plc
AMRN•NASDAQ
Healthcare
Biotechnology
$14.99
$-0.39(-2.57%)
Amarin Corporation plc (AMRN) Financial Performance & Income Statement Overview
Review Amarin Corporation plc’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-25.51%
↓ 25.51%
Operating Income Growth
-35.82%
↓ 35.82%
Net Income Growth
-39.03%
↓ 39.03%
Operating Cash Flow Growth
-551.06%
↓ 551.06%
Operating Margin
-44.34%
↓ 44.34%
Gross Margin
34.50%
↑ 34.50%
Net Profit Margin
-41.05%
↓ 41.05%
ROE
-17.21%
↓ 17.21%
ROIC
-19.25%
↓ 19.25%
Amarin Corporation plc (AMRN) Income Statement & Financial Overview
Review Amarin Corporation plc's (AMRN) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $42.02M | $62.31M | $42.30M | $67.57M |
| Cost of Revenue | $16.89M | $71.87M | $26.02M | $25.51M |
| Gross Profit | $25.13M | -$9.57M | $16.28M | $42.05M |
| Gross Profit Ratio | $0.60 | -$0.15 | $0.38 | $0.62 |
| R&D Expenses | $5.31M | $5.99M | $4.54M | $3.99M |
| SG&A Expenses | $36.57M | $36.95M | $36.90M | $38.59M |
| Operating Expenses | $41.88M | $42.95M | $41.44M | $42.58M |
| Total Costs & Expenses | $58.77M | $90.77M | $67.47M | $68.09M |
| Interest Income | $2.87M | $3.38M | $3.37M | $3.27M |
| Interest Expense | $0.00 | $7000.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $730000.00 | $737000.00 | $753000.00 | $761853.00 |
| EBITDA | -$16.02M | -$37.18M | -$24.41M | $237000.00 |
| EBITDA Ratio | -$0.38 | -$0.60 | -$0.58 | $0.004 |
| Operating Income | -$16.75M | -$52.53M | -$25.17M | -$524000.00 |
| Operating Income Ratio | -$0.40 | -$0.84 | -$0.60 | -$0.008 |
| Other Income/Expenses (Net) | -$1.009M | $2.62M | $3.42M | $3.42M |
| Income Before Tax | -$13.63M | -$49.91M | -$21.75M | $2.90M |
| Income Before Tax Ratio | -$0.32 | -$0.80 | -$0.51 | $0.04 |
| Income Tax Expense | -$2.07M | -$1.29M | $3.60M | $1.37M |
| Net Income | -$15.70M | -$48.62M | -$25.13M | $1.52M |
| Net Income Ratio | -$0.37 | -$0.78 | -$0.59 | $0.02 |
| EPS | -$0.04 | -$0.12 | -$0.06 | $0.004 |
| Diluted EPS | -$0.80 | -$0.12 | -$0.06 | $0.004 |
| Weighted Avg Shares Outstanding | $413.42M | $410.94M | $411.15M | $410.85M |
| Weighted Avg Shares Outstanding (Diluted) | $413.42M | $410.94M | $411.15M | $411.39M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan